Skip to content
Application 212997
- Type
- ANDA
- Sponsor
- LANNETT CO INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 10MG BASE | No | No |
| 002 | DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 25MG BASE | No | No |
| 003 | DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 50MG BASE | No | No |
| 004 | DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 75MG BASE | No | No |
| 005 | DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 100MG BASE | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0527-4062 | Doxepin Hydrochloride | Doxepin Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 0527-4062 | Doxepin Hydrochloride | Doxepin Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 0527-4063 | Doxepin Hydrochloride | Doxepin Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 0527-4063 | Doxepin Hydrochloride | Doxepin Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 0527-4064 | Doxepin Hydrochloride | Doxepin Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 0527-4064 | Doxepin Hydrochloride | Doxepin Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 0527-4065 | Doxepin Hydrochloride | Doxepin Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 0527-4065 | Doxepin Hydrochloride | Doxepin Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 0527-4066 | Doxepin Hydrochloride | Doxepin Hydrochloride | Lannett Company, Inc. | ANDA | Current |
| 0527-4066 | Doxepin Hydrochloride | Doxepin Hydrochloride | Lannett Company, Inc. | ANDA | Current |